This single-center retrospective study evaluated outcomes of ESRD patients undergoing valve surgery based on whether they received either a mechanical or tissue valve. The study spanned the years 2002-2014, and included 64 mechanical and 151 tissue valve replacements.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Valve Disease
Cost Analysis of Physician Assistant Home Visit Program to Reduce Readmissions After Cardiac Surgery
August 23, 2016
This retrospective study analyzed the relative cost-effectiveness of a physician assistant home care (PAHC) program in terms of readmission rates, length of stay, and health care cost. The study hospital switched from a conventional discharge treatment plan (control) in September 2010 to a PAHC program.
August 11, 2016
Torsten Doenst of Friedrich Schiller University, Jena, Germany, discusses surgical strategies for challenges faced during minimally invasive mitral valve surgery.
August 9, 2016
The following video shows an Edwards SAPIEN 3 TMVR implanted through the apical Certitude delivery system in a patient with severe mitral insufficiency following a bioprosthetic failure.
August 5, 2016
This study investigated the mechanical properties of ePTFE sutures used for artificial chordae during mitral valve repair.
August 2, 2016
Data from two institutions were evaluated for the period 2002-2014 including 436 patients affected by endocarditis, of whom 18% were current intravenous drug users (IVDUs). IVDUs had a lower risk of operative mortality but had an increased rate of valve-related complications, mostly related to higher rates of reinfection.
July 28, 2016
Filmed at the 2016 STS Annual Meeting in Phoenix, Arizona, a group of experts discuss the future of aortic stenosis treatment.
July 25, 2016
The authors describe their findings in a multicenter retrospective review of clinical outcomes in 64 patients with severe mitral annular calcification considered poor candidates for traditional surgical mitral valve replacement, undergoing transcatheter mitral valve implantation with a balloon expandable prosthesis.
July 14, 2016
This article explores the controversial topic of TAVR versus surgical AVR in low-risk patients. The primary outcome was 3-year survival. The authors report 3-year survival for TAVR and surgical AVR as 72% and 83.4%, respective (p=0.0015). Although TAVR is an exciting technology, there should be caution in adopting it in lower risk patients.
July 13, 2016
The authors enrolled 149 patients on DAPT undergoing urgent cardiac surgery in a prospective study analyzing the association between platelet reactivity and postoperative bleeding. They found that decreasing platelet reactivity correlated with an increase in calculated red blood cell loss after surgery.